Editorial
Free Access
Liver transplantation for patients with hepatitis B: What have we learned from our results?
John R. Lake M.D.,
Teresa L. Wright M.D.,
Corresponding Author
John R. Lake M.D.
Department of Medicine and Liver Center, University of California, San Francisco, California 94143
Box 0538, 1120 HSW, University of California, San Francisco, CA 94143===Search for more papers by this authorTeresa L. Wright M.D.
Veterans Administration Medical Center, San Francisco, California 94121
Search for more papers by this authorJohn R. Lake M.D.,
Teresa L. Wright M.D.,
Corresponding Author
John R. Lake M.D.
Department of Medicine and Liver Center, University of California, San Francisco, California 94143
Box 0538, 1120 HSW, University of California, San Francisco, CA 94143===Search for more papers by this authorTeresa L. Wright M.D.
Veterans Administration Medical Center, San Francisco, California 94121
Search for more papers by this author
References
- 1 Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. HEPATOLOGY 1991; 13: 619–626.
- 2 Yoffe B, Burns DK, Bhatt HS, Donegan E, Ferrell L, Ascher WL, Roberts JP, et al. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. HEPATOLOGY 1990; 12: 187–192.
- 3 Feray C, Zignegno AL, Samuel D, et al. Persistent hepatitis B virus infection of blood mononuclear cells without concomitant liver infection: the liver transplantation model. Transplantation 1990; 49: 1155–1158.
- 4 Wright T, Zeldis JB, Mamish D, et al. Graft infection with hepatitis B (HBV) following liver transplantation (OLTx): prognostic importance of viral replication [Abstract]. HEPATOLOGY 1990; 12: 867.
- 5 Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Iwaki Y, Sysyn G, Ming W, et al. Evolution of hepatitis B virus liver disease after hepatic replacement: practical and theoretical considerations. Am J Pathol 1990; 137: 667–676.
- 6 Rakela J, Wooten RS, Batts KP, Perkins JD Taswell HF, Krom RA. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 1989; 64: 429–432.
- 7 Mora NP, Klintmalm GB, Poplawski SS, Cofer JB, Husberg BS, Gonwa TA, Goldstein RM. Recurrence of hepatitis B after liver transplantation: does hepatitis B immunoglobulin modify the recurrent disease? Transplant Proc 1990; 22: 1547–1548.
- 8 Levy GA, Sherker A, Fung LS, Greig PD, Sherman M, Blendis LM. Relevance of hepatitis B viral DNA in assessment of potential liver allograft recipients. Transplant Proc 1989; 21: 3333–3334.
- 9 Rizzetto M, Macagno S, Chiaberge E, Verme G, Negro F, Marinucci G, Di Giacomo C, et al. Liver transplantation in hepatitis delta virus disease. Lancet 1987; 2: 469–471.
- 10 Grendele M, Colledan M, Gridelli B, Rossi G, Fassati LR, Ferla G, Maggi U, et al. Does the experience with liver transplantation suggest that hepatitis delta virus is not cytopathic? Transplant Proc 1990; 22: 1551–1553.
- 11 Colledan M, Grendele M, Gridelli B, Rossi G, Fassati LR, Ferla G, Doglia M, et al. Long-term results after liver transplantation in B and delta hepatitis. Transplant Proc 1989; 21: 2421–2423.
- 12 Agnes S, Avolio AW, Magalini SC, Nanni G, Foco M, Serino F, Hassan G, et al. Results of liver transplantation for hepatitis delta disease without immunoprophylaxis. Transplant Proc 1989; 21: 2426–2428.
- 13 Reynés M, Zignego L, Samuel D, Fabiani B, Gugenheim J, Tricottet V, Brechot C, et al. Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis. Transplant Proc 1989; 21: 2424–2425.
- 14 Purcell RH, Rizetto M, Gerin JL. Hepatitis delta infection of the liver. Semin Liver Dis 1984; 4: 340–346.
- 15 Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuals J, Rueff B, Benhamou JP. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107: 337–341.
- 16 Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583–1588.
- 17 Lauchart W, Muller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 2387–2389.
- 18 Lauchart W, Muller R, Pichlmayr R. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 4051–4053.
- 19 Blumhardt G, Neuhaus P, Bechstein WO, Steffen R, Hopf U, Meoller B, Raakow A. Liver transplantation in HBsAg positive patients. Transplant Proc 1990; 22: 1517–1518.
- 20 Perrillo RP, Schiff ER, Davis GL, Bodenheimer HZ Jr, Lindsay K, Payne J, Dienstag JL, et al. A randomized trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1989; 323: 295–301.
- 21 Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C, et al. Randomized, controlled trials of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318–1325.
- 22 White HM, Brunt EM, Regenstein F, Hanto DW, Marsh JW, Peters MG. Effect of alpha-interferon and immune globulin therapy on hepatitis B viral infection in transplanted liver recipients [Abstract]. HEPATOLOGY 1990; 12: 867.
- 23 Persing DH, Varmus HE, Ganem D. Inhibition of secretion of HBsAg by a related pre-surface polypeptide. Science 1986; 234: 1388–1391.
- 24 Czisari FB, Klopchin K, Moryama T, Pasquinelli C, Dunsford HA, Fell S, Pinkert CA, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156.
